消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2021 德国 S1 指南：肝血管病的诊断和治疗

2021-11-15 德国皮肤病学会 JDDG

肝脏疾病肝血管病

肝血管病的发病机制尚不清楚。然而，已经确定，在微调止血过程中，大量促凝血因子会导致真皮上部和中部微循环中血栓形成，并伴有连续的皮肤缺血（皮肤梗死）。

中文标题：

2021 德国 S1 指南：肝血管病的诊断和治疗

英文标题：

German S1 guideline: diagnosis and treatment of livedovasculopathy

发布机构：

德国皮肤病学会

发布日期：

2021-11-15

简要介绍：

肝血管病的发病机制尚不清楚。然而，已经确定，在微调止血过程中，大量促凝血因子会导致真皮上部和中部微循环中血栓形成，并伴有连续的皮肤缺血（皮肤梗死）。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 德国 S1 指南：肝血管病的诊断和治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=eb6a11c0023038aa, title=2021 德国 S1 指南：肝血管病的诊断和治疗, enTitle=German S1 guideline: diagnosis and treatment of livedovasculopathy, guiderFrom=JDDG, authorId=0, author=, summary=肝血管病的发病机制尚不清楚。然而，已经确定，在微调止血过程中，大量促凝血因子会导致真皮上部和中部微循环中血栓形成，并伴有连续的皮肤缺血（皮肤梗死）。, cover=https://img.medsci.cn/20211227/1640586804883_1608702.png, journalId=0, articlesId=null, associationId=2255, associationName=德国皮肤病学会 , associationIntro=德国皮肤病学会 (DDG), copyright=0, guiderPublishedTime=Mon Nov 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #1c1d1e;">肝血管病的发病机制尚不清楚。</span><span style="color: #1c1d1e;">然而，已经确定，在微调止血过程中，大量促凝血因子会导致真皮上部和中部微循环中血栓形成，并伴有连续的皮肤缺血（皮肤梗死）。</span></p>, tagList=[TagDto(tagId=6634, tagName=肝脏疾病), TagDto(tagId=120512, tagName=肝血管病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=95425, guiderKeyword=肝血管, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2940, appHits=88, showAppHits=0, pcHits=312, showPcHits=2851, likes=0, shares=4, comments=8, approvalStatus=1, publishedTime=Mon Dec 27 14:22:20 CST 2021, publishedTimeString=2021-11-15, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Mon Dec 27 14:42:17 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sun Dec 31 12:19:12 CST 2023, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 德国 S1 指南：肝血管病的诊断和治疗.pdf)])
2021 德国 S1 指南：肝血管病的诊断和治疗.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2143285, encodeId=49352143285b0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8d88266800, createdName=ms3000000173679460, createdTime=Sat Jun 17 09:03:38 CST 2023, time=2023-06-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1196491, encodeId=37dd1196491dc, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbbe5723169, createdName=ms7000001877390906, createdTime=Wed Feb 23 18:22:08 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179148, encodeId=1ab411e914820, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/3dac6c023a2227430f582458b92baf75.jpg, createdBy=a0242124870, createdName=1881fb789am, createdTime=Fri Dec 31 10:24:02 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085044, encodeId=5fde108504402, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Oiaecicujl2wfpBkKyhZ6gwISPy9rBt6nOxLXG0QhflNATVnicPmib6zX885nmcdZh0mEqTbaSWeftY7CcwDnSvduw/132, createdBy=bca42490282, createdName=米师, createdTime=Tue Dec 28 10:14:38 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084978, encodeId=b36310849e833, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 28 07:00:19 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-06-17 ms3000000173679460 来自四川省

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2143285, encodeId=49352143285b0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8d88266800, createdName=ms3000000173679460, createdTime=Sat Jun 17 09:03:38 CST 2023, time=2023-06-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1196491, encodeId=37dd1196491dc, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbbe5723169, createdName=ms7000001877390906, createdTime=Wed Feb 23 18:22:08 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179148, encodeId=1ab411e914820, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/3dac6c023a2227430f582458b92baf75.jpg, createdBy=a0242124870, createdName=1881fb789am, createdTime=Fri Dec 31 10:24:02 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085044, encodeId=5fde108504402, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Oiaecicujl2wfpBkKyhZ6gwISPy9rBt6nOxLXG0QhflNATVnicPmib6zX885nmcdZh0mEqTbaSWeftY7CcwDnSvduw/132, createdBy=bca42490282, createdName=米师, createdTime=Tue Dec 28 10:14:38 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084978, encodeId=b36310849e833, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 28 07:00:19 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-02-23 ms7000001877390906

    感谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2143285, encodeId=49352143285b0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8d88266800, createdName=ms3000000173679460, createdTime=Sat Jun 17 09:03:38 CST 2023, time=2023-06-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1196491, encodeId=37dd1196491dc, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbbe5723169, createdName=ms7000001877390906, createdTime=Wed Feb 23 18:22:08 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179148, encodeId=1ab411e914820, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/3dac6c023a2227430f582458b92baf75.jpg, createdBy=a0242124870, createdName=1881fb789am, createdTime=Fri Dec 31 10:24:02 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085044, encodeId=5fde108504402, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Oiaecicujl2wfpBkKyhZ6gwISPy9rBt6nOxLXG0QhflNATVnicPmib6zX885nmcdZh0mEqTbaSWeftY7CcwDnSvduw/132, createdBy=bca42490282, createdName=米师, createdTime=Tue Dec 28 10:14:38 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084978, encodeId=b36310849e833, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 28 07:00:19 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-31 1881fb789am

    感谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2143285, encodeId=49352143285b0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8d88266800, createdName=ms3000000173679460, createdTime=Sat Jun 17 09:03:38 CST 2023, time=2023-06-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1196491, encodeId=37dd1196491dc, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbbe5723169, createdName=ms7000001877390906, createdTime=Wed Feb 23 18:22:08 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179148, encodeId=1ab411e914820, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/3dac6c023a2227430f582458b92baf75.jpg, createdBy=a0242124870, createdName=1881fb789am, createdTime=Fri Dec 31 10:24:02 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085044, encodeId=5fde108504402, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Oiaecicujl2wfpBkKyhZ6gwISPy9rBt6nOxLXG0QhflNATVnicPmib6zX885nmcdZh0mEqTbaSWeftY7CcwDnSvduw/132, createdBy=bca42490282, createdName=米师, createdTime=Tue Dec 28 10:14:38 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084978, encodeId=b36310849e833, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 28 07:00:19 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 米师

    感谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2143285, encodeId=49352143285b0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8d88266800, createdName=ms3000000173679460, createdTime=Sat Jun 17 09:03:38 CST 2023, time=2023-06-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1196491, encodeId=37dd1196491dc, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbbe5723169, createdName=ms7000001877390906, createdTime=Wed Feb 23 18:22:08 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179148, encodeId=1ab411e914820, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/3dac6c023a2227430f582458b92baf75.jpg, createdBy=a0242124870, createdName=1881fb789am, createdTime=Fri Dec 31 10:24:02 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085044, encodeId=5fde108504402, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Oiaecicujl2wfpBkKyhZ6gwISPy9rBt6nOxLXG0QhflNATVnicPmib6zX885nmcdZh0mEqTbaSWeftY7CcwDnSvduw/132, createdBy=bca42490282, createdName=米师, createdTime=Tue Dec 28 10:14:38 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084978, encodeId=b36310849e833, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 28 07:00:19 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 微探

    学习学习

    0

相关指南

2021 APASL药物性肝损伤共识指南解读

北京中医药大学第一临床医学院 · 2021-08-28

2021 意大利临床实践指南：成人非酒精性脂肪性肝病

意大利肝病学会(AISF,Italian Association for the Study of the Liver) · 2021-12-16

《APASL慢性乙型肝炎患者停用核苷(酸)类似物指导意见》解读

国家重大公共卫生事件医学中心华中科技大学同济医学院附属同济医院感染科 · 2021-10-20

2021 EASL实践指南：肝脏疾病严重程度及预后的无创检测（更新版）

欧洲肝脏研究学会(EASL,European Association for the Study of the Liver) · 2021-06-03

肝脏局灶性病变CT和MRI标注专家共识（2020）

中华医学会放射学分会(CSR,chinese society of radiology) · 2020-12-20

2016年美国胃肠病学院临床指南：肝脏疾病与妊娠(中文)

美国胃肠病学院(ACG,American College of Gastroenterology) · 2016-06-08